Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
On-demand Video: Idea to Clinic – AIM to Reduce your Manufacturing Timeline by ~30%
